RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Titan Medical - Stock

Titan Medical Equity 2024

Titan Medical Equity

4.78 M USD

Ticker

TMD.TO

ISIN

CA88830X8199

WKN

A2JN66

In 2024, Titan Medical's equity was 4.78 M USD, a -251.23% increase from the -3.16 M USD equity in the previous year.

Titan Medical Aktienanalyse

What does Titan Medical do?

Titan Medical Inc is a company specialized in the development of robotic systems for minimally invasive procedures in the field of medicine. It was founded in 2008 in Toronto, Canada by Reiza Rayman and Dmitry Oleynikov. The main goal of Titan Medical was to revolutionize surgery by developing innovative systems that enable more precise, less invasive, and more effective medical treatments. The business model of Titan Medical is based on the development, manufacturing, and marketing of robotic systems for minimally invasive surgical procedures. The main area of focus for Titan Medical is the development and distribution of robotic systems for urological, gynecological, and endoscopic surgery. These systems contribute to improving patient treatment and speeding up recovery by operating more precisely and safely than traditional surgical methods. The flagship product of Titan Medical is the Sport-Surgery System (STS), specifically designed for sports medicine, orthopedics, and spinal surgery. The STS technology provides an enhanced view of the surgical field, reducing the risk of injuries and complications. The STS system by Titan Medical is unique and stands out for its wireless operation, compatibility with conventional instruments, and ability to integrate different imaging modalities. Another product offered by Titan Medical is the Single-Port version of the Sport-Surgery System. This system is the first robotic system capable of performing minimally invasive surgery through a single incision. The system offers faster recovery, reduces scarring, and potential complications. The Single-Port version by Titan Medical is a unique product in the market and has the potential to revolutionize the practice of minimally invasive surgery. Titan Medical operates research and development departments in Toronto, Canada, and Chapel Hill, North Carolina, USA. These departments work on the development of new technologies aimed at improving surgery and enhancing patients' quality of life. The company collaborates with universities and clinics to test and validate innovative technologies. Titan Medical aims to market its products worldwide. The company works with distribution partners and distributors in North America, Europe, Asia, and Australia to place its products in different markets. Titan Medical places particular emphasis on training and supporting its customers to ensure the maximum efficiency and effectiveness of its products. In 2014, Titan Medical went public and has been listed on the Toronto Stock Exchange and NASDAQ since then. The company has experienced strong growth in recent years and has become an innovative leader in robotic surgery. Titan Medical has received numerous awards and recognition for its innovative products and technologies, including the Innovation Technology Award and the Medical Device Excellence Award. Overall, Titan Medical is a company specialized in the development of robotic systems for minimally invasive surgery. The company aims to make surgical procedures safer and more precise while speeding up patient recovery. By collaborating with universities and clinics, Titan Medical continuously works on developing new technologies and products to push the boundaries of minimally invasive surgery and improve patient care. Titan Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Titan Medical's Equity

Titan Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Titan Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Titan Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Titan Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Titan Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Titan Medical stock

What is the equity of Titan Medical this year?

Titan Medical has equity of 4.78 M USD this year.

What was the equity of Titan Medical compared to the previous year?

The equity of Titan Medical has increased/decreased by -251.23% decreased compared to the previous year.

What impact does a high equity have on investors of Titan Medical?

A high equity is advantageous for investors of Titan Medical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Titan Medical?

A low equity can be a risk for investors of Titan Medical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Titan Medical affect the company?

An increase in equity of Titan Medical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Titan Medical affect the company?

A reduction in equity of Titan Medical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Titan Medical?

Some factors that can affect the equity of Titan Medical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Titan Medical so important for investors?

The equity of Titan Medical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Titan Medical take to change the equity?

To change equity, Titan Medical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Titan Medical pay?

Over the past 12 months, Titan Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Titan Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Titan Medical?

The current dividend yield of Titan Medical is .

When does Titan Medical pay dividends?

Titan Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Titan Medical?

Titan Medical paid dividends every year for the past 0 years.

What is the dividend of Titan Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Titan Medical located?

Titan Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Titan Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Titan Medical from 7/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/6/2024.

When did Titan Medical pay the last dividend?

The last dividend was paid out on 7/6/2024.

What was the dividend of Titan Medical in the year 2023?

In the year 2023, Titan Medical distributed 0 USD as dividends.

In which currency does Titan Medical pay out the dividend?

The dividends of Titan Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Titan Medical

Our stock analysis for Titan Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Titan Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.